Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.

Preliminary data from recent clinical radioimmunoscintigraphy studies indicate that 99mTc-labelled murine monoclonal antibodies (MAbs) E48 and U36 have a similar ability to target squamous cell carcinoma of the head and neck (HNSCC) selectively. In the present study we describe additional aspects of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: de Bree, R., Roos, J. C., Plaizier, M. A., Quak, J. J., van Kamp, G. J., den Hollander, W., Snow, G. B., van Dongen, G. A.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1997
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2222739/
https://ncbi.nlm.nih.gov/pubmed/9083342
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados